You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
佐力藥業(300181.SZ):佐力創新醫療收到科濟開曼頒發的Pre-C輪投資持股證書
格隆匯 03-19 21:07

格隆匯3月19日丨佐力藥業(300181.SZ)公佈,2018年2月以來,根據《融資框架協議》,科濟生物進行了重組和架構調整,以境外CARsgenTherapeutics Holdings Limited(“科濟開曼”)作為融資主體,佐力創新醫療及其他投資人均已完成了ODI備案和對科濟開曼的出資。近日,佐力創新醫療收到了科濟開曼頒發的Pre-C輪投資持股證書。佐力創新醫療現持有科濟開曼的股份數及持股比例詳見下表:

1佐力創新醫療20161參與了科濟生物B輪融資完成B輪出資持有濟生物7.85%股權科濟生物進行了重組、架構調整和Pre-C融資佐力創新醫療直接持有科濟開曼B股份,持股比例被稀釋至6.54%

2佐力創新醫療Pre-C對科濟開曼出資人民幣1300萬元)按照1美元摺合6.5人民幣計算,摺合200美元)。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account